Peginterferon alfa-2a and Ribavirin Combination Therapy in Patients with HBeAg-negative Chronic HBV Infection

Update Il y a 4 ans
Reference: EUCTR2004-004736-30

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To investigate whether in patients with chronic HBeAg-negative hepatitis B PEG-IFN-ribavirin combination therapy for 1 year leads to enhanced response (HBV DNA <104 copies/ml and normal ALT 24 weeks after treatment discontinuation) in comparison with PEG-IFN monotherapy.


Inclusion criteria

  • chronic HBV infection